Clinical Trial Update: Phase 2, Open-Label Study to Evaluate the Safety and Tolerability of Progerinin in Werner Syndrome [Phase 2]

View source ↗

Summary

Phase 2 open-label study to evaluate the safety and tolerability of Progerinin in Werner syndrome; the trial is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Werner Syndrome

Drugs mentioned

• Progerinin

Snippet

Sponsor: PRG Science & Technology Co., Ltd. | Conditions: Werner Syndrome | Phase 2 | Status: NOT_YET_RECRUITING